Executive Summary: From the Medical Board of the National Psoriasis Foundation: Perioperative management of immunomodulatory agents in patients with psoriasis and psoriatic arthritis

Warren A James; Angela L Rosenberg; Jashin J Wu; Sylvia Hsu; April Armstrong; Elizabeth B Wallace; Lara Wine Lee; Joseph Merola; Sergio Schwartzman; Dafna Gladman; Clive Liu; John Koo; Jason E Hawkes; Soumya Reddy; Ron Prussick; Paul Yamauchi; Michael Lewitt; Jennifer Soung; Jeffery Weinberg; Mark Lebwohl; Brad Glick; Leon Kircik; Seemal Desai; Steven R Feldman; Mallory L Zaino

doi:10.1016/j.jaad.2024.03.008

Executive Summary: From the Medical Board of the National Psoriasis Foundation: Perioperative management of immunomodulatory agents in patients with psoriasis and psoriatic arthritis

J Am Acad Dermatol. 2024 Mar 16:S0190-9622(24)00497-3. doi: 10.1016/j.jaad.2024.03.008. Online ahead of print.

Authors

Warren A James¹, Angela L Rosenberg¹, Jashin J Wu², Sylvia Hsu³, April Armstrong⁴, Elizabeth B Wallace⁵, Lara Wine Lee⁶, Joseph Merola⁷, Sergio Schwartzman⁸, Dafna Gladman⁹, Clive Liu¹⁰, John Koo¹¹, Jason E Hawkes¹², Soumya Reddy¹³, Ron Prussick¹⁴, Paul Yamauchi¹⁵, Michael Lewitt¹⁶, Jennifer Soung¹⁷, Jeffery Weinberg¹⁸, Mark Lebwohl¹⁸, Brad Glick¹⁹, Leon Kircik²⁰, Seemal Desai²¹, Steven R Feldman²², Mallory L Zaino²³

Affiliations

¹ Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
² Department of Dermatology, University of Miami Miller School of Medicine.
³ Temple University School of Medicine, Philadelphia, Pennsylvania.
⁴ Keck School of Medicine at USC, Los Angeles, California.
⁵ Cherry Hills Dermatology, Englewood, Colorado.
⁶ Medical University of South Carolina, Charleston, South Carolina.
⁷ Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts.
⁸ 72nd Street Medical Associates, New York, New York.
⁹ University of Toronto, Toronto, Ontario, Canada.
¹⁰ Bellevue Dermatology, Bellevue, Washington.
¹¹ University of California, San Francisco Medical Center, San Francisco, California.
¹² University of California, Davis, Rocklin, California.
¹³ NYU Grossman School of Medicine, New York, New York.
¹⁴ Washington Dermatology Center, Frederick, Maryland.
¹⁵ Dermatology Institute & Skin Care Center Santa Monica, California.
¹⁶ Illinois Dermatology Institute, LLC, Chicago, Illinois.
¹⁷ Southern California Dermatology, Santa Ana, California.
¹⁸ Icahn School of Medicine at Mount Sinai, New York, New York.
¹⁹ Glick Skin Institute, Margate, Florida.
²⁰ Physicians Skin Care, Louisville, Kentucky.
²¹ Innovative Dermatology, Plano, Texas.
²² Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina;; Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina;; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina;; Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina.
²³ Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina;. Electronic address: mlzain01@louisville.edu.

PMID: 38499181
DOI: 10.1016/j.jaad.2024.03.008

No abstract available

Keywords: IL-12/23 inhibitor; IL-17 inhibitor; IL-23 inhibitor; abatacept; acitretin; apremilast; biologic; cyclosporine; immunosuppressant; methotrexate; perioperative; psoriasis; psoriatic arthritis; tofacitinib; tumor necrosis factor-alpha inhibitors.